<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04525625</url>
  </required_header>
  <id_info>
    <org_study_id>AKI-ACLF</org_study_id>
    <nct_id>NCT04525625</nct_id>
  </id_info>
  <brief_title>Risk Factors for Acute Kidney Injury in Critically Ill Patients With Acute-on-Chronic Liver Failure</brief_title>
  <official_title>Risk Factors for Acute Kidney Injury in Critically Ill Patients With Acute-on-Chronic Liver Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institutul Clinic Fundeni</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institutul Clinic Fundeni</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acute kidney injury (AKI) is one of the most important factors associated with increased&#xD;
      mortality in patients with acute-on-chronic liver failure (AoCLF). Early identification and&#xD;
      treatment of this subgroup of patients may improve survival and decrease ICU length of stay.&#xD;
      As kidney ischemia is one of the main mechanisms responsible for AKI in AoCLF, an increase in&#xD;
      urinary to arterial partial pressure of oxygen may help in the early diagnosis of renal&#xD;
      failure. For this arterial and urinary oxygen pressure will be measured at ICU admission, on&#xD;
      day 1 and day 3 of ICU stay. Diagnosis of AKI within the first 28 days after ICU admission&#xD;
      will be recorded&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>AKI</measure>
    <time_frame>28 days after ICU admission</time_frame>
    <description>incidence (%) of AKI in patients with AoCLF as defined by Acute Kidney Injury Network guidelines</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>arterial to urinary oxygen gradient</measure>
    <time_frame>ICU admission, ICU day 1 and ICU dy 3</time_frame>
    <description>mathematical difference in oxygen partial pressure between arterial blood and urine (mmHg) in patients with AKI compared to patients without AKI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mortality</measure>
    <time_frame>28-days</time_frame>
    <description>28-day mortality</description>
  </secondary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Acute Kidney Injury</condition>
  <condition>Acute-On-Chronic Liver Failure</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All consecutive patients admitted to a general ICU for ACLF who fall into the inclusion and&#xD;
        exclusion criteria. Standard treatment will be applied to all patients and no supplemental&#xD;
        intervention is required for the present study.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - patients admitted to the ICU for acute-on-chronic liver failure&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pre-existing renal disease&#xD;
&#xD;
          -  urine output&lt;200 mL/day&#xD;
&#xD;
          -  death within the first 24 hours after ICU admission&#xD;
&#xD;
          -  emergency liver transplantation within the follow-up period (28 days)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dana Tomescu, Prof</last_name>
    <role>Study Chair</role>
    <affiliation>Fundeni Clinical Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dana Tomescu, Prof</last_name>
    <phone>0040722300288</phone>
    <email>danatomescu@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mihai Popescu, Assoc Prof</last_name>
    <email>mihai.popescu@umfcd.ro</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Popescu Mihai</name>
      <address>
        <city>Bucharest</city>
        <zip>022328</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Popescu Mihai, MD PhD</last_name>
      <phone>0040751075995</phone>
      <email>lcf4ever@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Romania</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>August 21, 2020</study_first_submitted>
  <study_first_submitted_qc>August 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 25, 2020</study_first_posted>
  <last_update_submitted>September 3, 2021</last_update_submitted>
  <last_update_submitted_qc>September 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Institutul Clinic Fundeni</investigator_affiliation>
    <investigator_full_name>Popescu Mihai</investigator_full_name>
    <investigator_title>clinical professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Failure</mesh_term>
    <mesh_term>Hepatic Insufficiency</mesh_term>
    <mesh_term>End Stage Liver Disease</mesh_term>
    <mesh_term>Acute-On-Chronic Liver Failure</mesh_term>
    <mesh_term>Acute Kidney Injury</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

